Concepedia

Kevin P. Craig

KP

Statistics

Publications

3

Citations

202

H-Index

3

Active since

2016

Affiliations

Dicerna Pharmaceuticals (United States)(Current)

Kevin P. Craig is an author at Dicerna Pharmaceuticals (United States) specializing in cancer cell biology, medicine, and cell biology.

Top concepts

Publications per year

2016–2018

3

Publications

3

RNAi-Mediated β-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade

Shanthi Ganesh, Xue Shui, Kevin P. Craig et al. · Molecular Therapy · 2018 · 120 citations · Full text

, , +18

Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin

Shanthi Ganesh, Martin L. Koser, Wendy A. Cyr et al. · Molecular Cancer Therapeutics · 2016 · 61 citations · Full text

, , +21

β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models

Shanthi Ganesh, Xue Shui, Kevin P. Craig et al. · Molecular Cancer Therapeutics · 2017 · 21 citations · Full text

1–3 of 3